enVVeno Medical Corporation
$12.08
▲
3.74%
2026-04-21 08:31:01
www.envveno.com
NCM: NVNO
Explore enVVeno Medical Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$7.92 M
Current Price
$12.08
52W High / Low
$196.7 / $8.67
Stock P/E
—
Book Value
$41.36
Dividend Yield
—
ROCE
-76.16%
ROE
-56.21%
Face Value
—
EPS
$-33.06
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
33
Beta
1.09
Debt / Equity
2.58
Current Ratio
13.58
Quick Ratio
13.58
Forward P/E
-9.29
Price / Sales
—
Enterprise Value
$-20.27 M
EV / EBITDA
0.98
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | DexCom, Inc. | $63.4 | 30.77 | $24.57 B | — | 21.72% | 34.5% | $89.98 / $54.11 | $7.14 |
| 2. | QuidelOrtho Corporation | $12.89 | — | $877.57 M | — | 1.14% | -46.15% | $38.99 / $11.61 | $28.28 |
| 3. | Elutia Inc. | $1.12 | 0.92 | $49.2 M | — | -49.48% | -574.35% | $2.64 / $0.5 | $0.65 |
| 4. | iTonic Holdings Ltd. | $0.32 | — | $5.41 M | — | -59.82% | -71.25% | $32 / $0.25 | $0.36 |
| 5. | HeartSciences Inc. | $2.05 | — | $6.85 M | — | -1607.2% | -3.82% | $6.47 / $1.89 | $0.83 |
| 6. | Autonomix Medical, Inc. | $0.4 | — | $4.63 M | — | -143.08% | -1.89% | $2.82 / $0.34 | $0.75 |
| 7. | NeuroOne Medical Technologies Corporation | $4.98 | — | $40.89 M | — | -49.83% | -1.46% | $6.96 / $3 | $0.13 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -4.01 M | -4.88 M | -7.05 M | -4.95 M | -6.7 M | — |
| Net Profit | -3.74 M | -4.54 M | -6.69 M | -4.5 M | -6.23 M | — |
| EPS in Rs | -5.7 | -6.92 | -10.21 | -6.87 | -9.5 | -12.25 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -20.9 M | -23.83 M | -25.24 M | -24.93 M |
| Net Profit | -19.47 M | -21.82 M | -23.52 M | -24.67 M |
| EPS in Rs | -29.7 | -33.28 | -35.87 | -37.63 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 29.56 M | 44.95 M | 48.63 M | 41.66 M |
| Total Liabilities | 2.43 M | 2.79 M | 2.44 M | 2.93 M |
| Equity | 27.13 M | 42.16 M | 46.2 M | 38.73 M |
| Current Assets | 28.83 M | 43.73 M | 46.92 M | 39.44 M |
| Current Liabilities | 2.12 M | 2.1 M | 1.37 M | 1.53 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -15.57 M | -16.84 M | -18.86 M | -15.62 M |
| Investing CF | 15.86 M | 1.33 M | -7.87 M | -34.55 M |
| Financing CF | 1.02 M | 13.64 M | 25.79 M | 0 M |
| Free CF | -15.57 M | -16.88 M | -18.89 M | -15.73 M |
| Capex | -0.01 M | -0.04 M | -0.03 M | -0.12 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | 7.22% | 4.67% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-01-20 | 1:0.0285714 |